Semi-Annual Balance Sheet

Carna Biosciences, Inc. - Filing #7732093

Concept As at
2017-09-30
As at
2016-12-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
1,945,763,000 JPY
2,161,186,000 JPY
Other
59,211,000 JPY
86,686,000 JPY
Current assets
2,217,538,000 JPY
2,492,690,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
21,077,000 JPY
35,136,000 JPY
Intangible assets
Intangible assets
500,000 JPY
787,000 JPY
Investments and other assets
Investments and other assets
37,130,000 JPY
37,681,000 JPY
Non-current assets
58,709,000 JPY
73,605,000 JPY
Assets
2,276,247,000 JPY
2,566,295,000 JPY
Liabilities
Current liabilities
Accounts payable - trade
JPY
3,495,000 JPY
Income taxes payable
12,688,000 JPY
4,959,000 JPY
Other
13,151,000 JPY
15,805,000 JPY
Current liabilities
254,151,000 JPY
271,428,000 JPY
Accounts payable - other
58,023,000 JPY
76,907,000 JPY
Non-current liabilities
Non-current liabilities
421,076,000 JPY
555,545,000 JPY
Bonds payable
144,000,000 JPY
172,000,000 JPY
Long-term borrowings
248,736,000 JPY
355,459,000 JPY
Asset retirement obligations
26,052,000 JPY
25,669,000 JPY
Other
2,288,000 JPY
2,416,000 JPY
Liabilities
675,228,000 JPY
826,974,000 JPY
Other liabilities
Other liabilities
Net assets
Share capital
3,223,291,000 JPY
3,042,759,000 JPY
Shareholders' equity
Capital surplus
Capital surplus
2,041,316,000 JPY
1,860,826,000 JPY
Retained earnings
Retained earnings
-3,677,958,000 JPY
-3,169,633,000 JPY
Treasury shares
-99,000 JPY
JPY
Shareholders' equity
1,586,550,000 JPY
1,733,952,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
76,000 JPY
57,000 JPY
Valuation and translation adjustments
-703,000 JPY
516,000 JPY
Net assets
1,601,019,000 JPY
1,739,321,000 JPY
Share acquisition rights
15,172,000 JPY
4,853,000 JPY
Liabilities and net assets
2,276,247,000 JPY
2,566,295,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.